• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性淋巴瘤:诊断、分期及治疗的最新进展

Malignant lymphoma: an update on diagnosis, staging, and management.

作者信息

Perlin E

出版信息

Prim Care. 1980 Sep;7(3):409-22.

PMID:6905202
Abstract

The diagnosis of malignant lymphoma is not difficult. The various subtypes of Hodgkin's disease are easily recognized by the pathologist. The non-Hodgkin's lymphomas can be distinguished from Hodgkin's disease but are more difficult to classify. Staging of the lymphomas has improved. Computerized axial tomography and ultrasonography have assisted in the evaluation of the abdomen. Laparotomy and splenectomy continues to be a useful procedure for the pathologic staging of Hodgkin's disease, but its value will require yearly reassessment as improvements in staging and management are made. The treatment of Hodgkin's disease has been very successful. The majority of patients can be cured of the disease. Therapy has not had a major impact on survival of patients with nodular lymphomas, but has considerably improved the prognosis of patients with diffuse lymphomas.

摘要

恶性淋巴瘤的诊断并不困难。病理学家很容易识别霍奇金病的各种亚型。非霍奇金淋巴瘤可与霍奇金病相鉴别,但分类更困难。淋巴瘤的分期已有所改进。计算机断层扫描和超声检查有助于腹部评估。剖腹术和脾切除术仍是霍奇金病病理分期的有用方法,但其价值将随着分期和治疗方法的改进而需要每年重新评估。霍奇金病的治疗非常成功。大多数患者可治愈该病。治疗对结节性淋巴瘤患者的生存率没有重大影响,但显著改善了弥漫性淋巴瘤患者的预后。

相似文献

1
Malignant lymphoma: an update on diagnosis, staging, and management.恶性淋巴瘤:诊断、分期及治疗的最新进展
Prim Care. 1980 Sep;7(3):409-22.
2
[Do we have to treat non-Hodgkin's lymphomas the same as Hodgkin's disease?].
Schweiz Med Wochenschr. 1975 Oct 4;105(40):1278-81.
3
[Therapy of malignant lymphomas].
Wien Klin Wochenschr. 1983 Feb 18;95(4):93-112.
4
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.大剂量异环磷酰胺联合依托泊苷和表柔比星(IVE方案)治疗复发/难治性霍奇金淋巴瘤和非霍奇金淋巴瘤:毒性和疗效报告
Eur J Haematol Suppl. 2001 Jul;64:28-32.
5
Laparotomy for staging of Hodgkin's and non-hodgkin's lymphoma.用于霍奇金淋巴瘤和非霍奇金淋巴瘤分期的剖腹术。
Surg Gynecol Obstet. 1977 Feb;144(2):208-10.
6
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)可预测侵袭性非霍奇金淋巴瘤和霍奇金病患者的预后。
Ann Hematol. 2006 Nov;85(11):759-67. doi: 10.1007/s00277-006-0151-z. Epub 2006 Jul 27.
7
[Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].[4型淋巴细胞消减型霍奇金病。35例病例的解剖临床回顾]
Bull Cancer. 1994 Oct;81(10):866-70.
8
Labeling index as a prognostic marker in non-Hodgkin's lymphomas.标记指数作为非霍奇金淋巴瘤的预后标志物
J Natl Cancer Inst. 1981 Jan;66(1):1-5.
9
The role of PET in lymphoma.正电子发射断层扫描(PET)在淋巴瘤中的作用。
J Nucl Med. 2006 Aug;47(8):1326-34.
10
Hodgkin's and non-Hodgkin's lymphomas.霍奇金淋巴瘤和非霍奇金淋巴瘤。
Br J Hosp Med. 1984 Jan;31(1):10-4, 18-9.